Fuchs’ Uveitis Syndrome: No Longer a Syndrome?

References

• Mohamed Q, Zamir E. Update on Fuchs’ uveitis syndrome. Curr Opin Ophthalmol. 2005;16:356–363
   PubMedGoogle Scholar
• Jones NP. Fuchs’ heterochromic uveitis: a reappraisal of the clinical spectrum. Eye. 1991;5:649–661
   PubMedGoogle Scholar
• Fuchs E. Ueber Komplicationen der Heterochromie. Z Augenheilk. 1906;15:191–212
   Google Scholar
• La Hey E, de Jong PT, Kijlstra A. Fuchs’ heterochromic cyclitis: review of the literature on the pathogenetic mechanisms. Br J Ophthalmol. 1994;78:307–312
   PubMed Web of Science ®Google Scholar
• Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol. 2004;138:46–54
   PubMed Web of Science ®Google Scholar
• de Groot-Mijnes JD, de Visser L, Rothova A, et al. Rubella virus is associated with Fuchs heterochromic iridocyclitis. Am J Ophthalmol. 2006;141:212–214
   PubMed Web of Science ®Google Scholar
• Ruokonen PC, Metzner S, Ucer A, et al. Intraocular antibody synthesis against rubella virus and other microorganisms in Fuchs’ heterochromic cyclitis. Graefe’s Arch Clin Exp Ophthalmol. 2010;248:565–571
   PubMed Web of Science ®Google Scholar
• Suzuki J, Goto H, Komase K, et al. Rubella virus as a possible etiological agent of Fuchs heterochromic iridocyclitis. Graefe’s Arch Clin Exp Ophthalmol. 2010;248:1487–1491
   PubMed Web of Science ®Google Scholar
• Stunf S, Petrovec M, Zigon N, et al. High concordance of intraocular antibody synthesis against the rubella virus and Fuchs heterochromic uveitis syndrome in Slovenia. Mol Vis. 2012;18:2909–2914
   PubMed Web of Science ®Google Scholar
• Wensing B, Relvas LM, Caspers LE, et al. Comparison of rubella virus- and herpes virus-associated anterior uveitis: clinical manifestations and visual prognosis. Ophthalmology. 2011;118:1905–1910
   PubMed Web of Science ®Google Scholar
• de Visser L, Braakenburg A, Rothova A, et al. Rubella virus-associated uveitis: clinical manifestations and visual prognosis. Am J Ophthalmol. 2008;146:292–297
   PubMed Web of Science ®Google Scholar
• Kanavi MR, Soheilian M, Yazdani S, Peyman GA. Confocal scan features of keratic precipitates in Fuchs heterochromic iridocyclitis. Cornea. 2010;29:39–42
   PubMed Web of Science ®Google Scholar
• Siemerink MJ, Sijssens KM, de Groot-Mijnes JD, de Boer JH. Rubella virus-associated uveitis in a nonvaccinated child. Am J Ophthalmol. 2007;143:899–900
   PubMed Web of Science ®Google Scholar
• Winchester SA, Varga Z, Parmar D, Brown KE. Persistent intraocular rubella infection in a patient with Fuchs’ uveitis and congenital rubella syndrome. J Clin Microbiol. 2013;51:1622–1624
   PubMed Web of Science ®Google Scholar
• Birnbaum AD, Tessler HH, Schultz KL, et al. Epidemiologic relationship between Fuchs heterochromic iridocyclitis and the United States rubella vaccination program. Am J Ophthalmol. 2007;144:424–428
   PubMed Web of Science ®Google Scholar
• Birnbaum AD, Little DM, Tessler HH, Goldstein DA. Etiologies of chronic anterior uveitis at a tertiary referral center over 35 years. Ocul Immunol Inflamm. 2011;19:19–25
   PubMed Web of Science ®Google Scholar
• Barequet IS, Li Q, Wang Y, et al. Herpes simplex virus DNA identification from aqueous fluid in Fuchs heterochromic iridocyclitis. Am J Ophthalmol. 2000;129:672–673
   PubMed Web of Science ®Google Scholar
• Chee SP, Jap A. Presumed Fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol. 2008;146:883–889 e1
   PubMed Web of Science ®Google Scholar
• Carmichael, A. Cytomegalovirus and the eye. Eye (Lond). 2012;26:237–240
   PubMed Web of Science ®Google Scholar
• Givens KT, Lee DA, Jones T, Ilstrup DM. Congenital rubella syndrome: ophthalmic manifestations and associated systemic disorders. Br J Ophthalmol. 1993;77:358–363
   PubMed Web of Science ®Google Scholar
• Kearns MJ, Plitt SS, Lee BE, Robinson JL. Rubella immunity among pregnant women in a Canadian provincial screening program. Can J Infect Dis Med Microbiol. 2009;20:73–77
   PubMed Web of Science ®Google Scholar
• Banatvala JE, Brown DW. Rubella. Lancet. 2004;363:1127–1137
   PubMed Web of Science ®Google Scholar
• Arnold JJ, McIntosh ED, Martin FJ, Menser MA. A fifty-year follow-up of ocular defects in congenital rubella: late ocular manifestations. Aust N Z J Ophthalmol. 1994;22:1–6
   PubMedGoogle Scholar
• Lovett AE, Hahn CS, Rice CM, et al. Rubella virus-specific cytotoxic T-lymphocyte responses: identification of the capsid as a target of major histocompatibility complex class I-restricted lysis and definition of two epitopes. J Virol. 1993;67:5849–5858
   PubMed Web of Science ®Google Scholar
• Adamo P, Asis L, Silveyra P, et al. Rubella virus does not induce apoptosis in primary human embryo fibroblast cultures: a possible way of viral persistence in congenital infection. Viral Immunol. 2004;17:87–100
   PubMed Web of Science ®Google Scholar
• Herrmann KL. Rubella in the United States: toward a strategy for disease control and elimination. Epidemiology and infection. 1991;107:55–61
   PubMed Web of Science ®Google Scholar
• Galazka A. Rubella in Europe. Epidemiol Infect. 1991;107:43–54
   PubMed Web of Science ®Google Scholar
• Atreya CD, Mohan KV, Kulkarni S. Rubella virus and birth defects: molecular insights into the viral teratogenesis at the cellular level. Birth Defects Res A Clin Mol Teratol. 2004;70:431–437
   PubMed Web of Science ®Google Scholar
• Garg RK. Subacute sclerosing panencephalitis. J Neurol. 2008;255:1861–1871
   PubMed Web of Science ®Google Scholar
• Frey TK, Abernathy ES, Bosma TJ, et al. Molecular analysis of rubella virus epidemiology across three continents, North America, Europe, and Asia, 1961–1997. J Infect Dis. 1998;178:642–650
   PubMed Web of Science ®Google Scholar
• Jones NP. Fuchs’ heterochromic uveitis: an update. Surv Ophthalmol. 1993;37:253–272
   PubMed Web of Science ®Google Scholar
• Aggarwal RK, Luck J, Coster DJ. Horner’s syndrome and Fuchs’ heterochromic uveitis. Br J Ophthalmol. 1994;78:949
   PubMed Web of Science ®Google Scholar
• Loewenfeld IE, Thompson HS. Fuchs’s heterochromic cyclitis—a critical review of the literature, II: aetiology and mechanism. Surv Ophthalmol. 1973;18:2–61
   Google Scholar
• Vega JL, Keino H, Masli S. Surgical denervation of ocular sympathetic afferents decreases local transforming growth factor-beta and abolishes immune privilege. Am J Pathol. 2009;175:1218–1225
   PubMed Web of Science ®Google Scholar
• Munoz G, Lopez-Corell MP, Taboada JF, et al. Fuch’s heterochromic cyclitis and HLA histocompatibility antigens. Int Ophthalmol. 1994;18:127–130
   PubMed Web of Science ®Google Scholar
• Saari M, Vuorre I, Tillikainen A, Algvere P. Genetic background of Fuchs’ heterochromic cyclitis. Can J Ophthmal. 1978;13:240–246
   PubMed Web of Science ®Google Scholar
• De Bruyere M, Dernouchamps JP, Sokal G. HLA antigens in Fuchs’ heterochromic iridocyclitis. Am J Ophthalmol. 1986;102:392–393
   PubMed Web of Science ®Google Scholar
• Arocker-Mettinger E, Steurer-Georgiew L, Steurer M, Huber-Spitzy V. Circulating ICAM-1 levels in serum of uveitis patients. Curr Eye Res. 1992;11:161–166
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Rebmann V, Neubert A, et al. Soluble HLA class I and HLA-DR plasma levels in patients with anterior uveitis. Tissue Antigens. 2004;63:369–375
   PubMed Web of Science ®Google Scholar
• Melamed S, Lahav M, Sandbank U, et al. Fuch’s heterochromic iridocyclitis: an electron microscopic study of the iris. Invest Ophthalmol Vis Sci. 1978;17:1193–1199
   PubMed Web of Science ®Google Scholar
• Goldberg MF, Erozan YS, Duke JR, Frost JK. Cytopathologic and histopathologic aspects of Fuchs’ heterochromic iridocyclitis. Arch Ophthalmol. 1965;74:604–609
   PubMed Web of Science ®Google Scholar
• McCartney AC, Bull TB, Spalton DJ. Fuchs’ heterochromic cyclitis: an electron microscopy study. Trans Ophthalmol Soc U K. 1986;105:324–329
   PubMedGoogle Scholar
• Muhaya M, Calder V, Towler HM, et al. Characterization of T cells and cytokines in the aqueous humour (AH) in patients with Fuchs’ heterochromic cyclitis (FHC) and idiopathic anterior uveitis (IAU). Clin Exp Immunol. 1998;111:123–128
   PubMed Web of Science ®Google Scholar
• Labalette P, Caillau D, Grutzmacher C, et al. Highly focused clonal composition of CD8(+) CD28(neg) T cells in aqueous humor of fuchs heterochromic cyclitis. Exp Eye Res. 2002;75:317–325
   PubMed Web of Science ®Google Scholar
• Milikan JC, Kuijpers RW, Baarsma GS, et al. Characterization of the varicella zoster virus (VZV)-specific intra-ocular T-cell response in patients with VZV-induced uveitis. Exp Eye Res. 2006;83:69–75
   PubMed Web of Science ®Google Scholar
• Murray PI, Clay CD, Mappin C, Salmon M. Molecular analysis of resolving immune responses in uveitis. Clin Exp Immunol. 1999;117:455–461
   PubMed Web of Science ®Google Scholar
• Strioga M, Pasukoniene V, Characiejus D. CD8+ CD28− and CD8+ CD57+ T cells and their role in health and disease. Immunology. 2011;134:17–32
   PubMed Web of Science ®Google Scholar
• Billerbeck E, Thimme R. CD8+ regulatory T cells in persistent human viral infections. Hum Immunol. 2008;69:771–775
   PubMed Web of Science ®Google Scholar
• Streilein JW. Ocular immune privilege:the eye takes a dim but practical view of immunity and inflammation. J Leukocyte Biol. 2003;74:179–185
   PubMed Web of Science ®Google Scholar
• Murray PI, Hoekzema R, Luyendijk L, et al. Analysis of aqueous humor immunoglobulin G in uveitis by enzyme-linked immunosorbent assay, isoelectric focusing, and immunoblotting. Invest Ophthalmol Vis Sci. 1990;31:2129–2135
   PubMed Web of Science ®Google Scholar
• Bloch-Michel E, Lambin P, Debbia M, et al. Local production of IgG and IgG subclasses in the aqueous humor of patients with Fuchs heterochromic cyclitis, herpetic uveitis and toxoplasmic chorioretinitis. Int Ophthalmol. 1997;21:187–194
   PubMed Web of Science ®Google Scholar
• Lacomba MS, Martin CM, Chamond RR, et al. Aqueous and serum interferon gamma, interleukin (IL) 2, IL-4, and IL-10 in patients with uveitis. Arch Ophthalmol. 2000;118:768–772
   PubMed Web of Science ®Google Scholar
• Suzuki K, Suzuki Y, Matsumoto M, Nakazawa M. Expression profile of intravitreous cytokines, chemokines and growth factors in patients with Fuchs heterochromic iridocyclitis. Case Rep Ophthalmol. 2010;1:5–13
   PubMedGoogle Scholar
• Murray PI, Hoekzema R, van Haren MA, et al. Aqueous humor interleukin-6 levels in uveitis. Invest Ophthalmol Vis Sci. 1990;31:917–920
   PubMed Web of Science ®Google Scholar
• Petrinovic-Doresic J, Mazuran R, Henc-Petrinovic L, et al. Interleukin 6 and its soluble receptor are elevated in aqueous humor of patients with uveitis. Ocul Immunol Inflamm. 1999;7:75–84
   PubMed Web of Science ®Google Scholar
• Santos Lacomba M, Marcos Martin C, Gallardo Galera JM, et al. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res. 2001;33:251–255
   PubMed Web of Science ®Google Scholar
• Curnow SJ, Falciani F, Durrani OM, et al. Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. Invest Ophthalmol Vis Sci. 2005;46:4251–4259
   PubMed Web of Science ®Google Scholar
• de Boer JH, Limpens J, Orengo-Nania S, et al. Low mature TGF-beta 2 levels in aqueous humor during uveitis. Invest Ophthalmol Vis Sci. 1994;35:3702–3710
   PubMed Web of Science ®Google Scholar
• Taylor AW. Review of the activation of TGF-beta in immunity. J Leukocyte Biol. 2009;85:29–33
   PubMed Web of Science ®Google Scholar
• Muhaya M, Calder VL, Towler HM, et al. Characterization of phenotype and cytokine profiles of T cell lines derived from vitreous humour in ocular inflammation in man. Clin Exp Immunol. 1999;116:410–414
   PubMed Web of Science ®Google Scholar
• Takase H, Futagami Y, Yoshida T, et al. Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. Invest Ophthalmol Vis Sci. 2006;47:1557–1561
   PubMed Web of Science ®Google Scholar
• Hill T, Galatowicz G, Akerele T, et al. Intracellular T lymphocyte cytokine profiles in the aqueous humour of patients with uveitis and correlation with clinical phenotype. Clin Exp Immunol. 2005;139:132–137
   PubMed Web of Science ®Google Scholar
• Curnow SJ, Murray PI. Inflammatory mediators of uveitis: cytokines and chemokines. Curr Opin Ophthalmol. 2006;17:532–537
   PubMed Web of Science ®Google Scholar
• Ooi KG, Galatowicz G, Calder VL, Lightman SL. Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype? Clin Med Res. 2006;4:294–309
   PubMedGoogle Scholar
• de Groot-Mijnes JD, de Visser L, Zuurveen S, et al. Identification of new pathogens in the intraocular fluid of patients with uveitis. Am J Ophthalmol. 2010;150:628–636
   PubMed Web of Science ®Google Scholar
• Chantler JK, Davies MA. The effect of antibody on rubella virus infection in human lymphoid cells. J Gen Virol. 1987;68:1277–1288
   PubMed Web of Science ®Google Scholar
• la Hey E, Baarsma GS, Rothova A, et al. High incidence of corneal epithelium antibodies in Fuch’s heterochromic cyclitis. Br J Ophthalmol. 1988;72:921–925
   PubMed Web of Science ®Google Scholar
• van der Gaag R, Broersma L, Rothova A, et al. Immunity to a corneal antigen in Fuchs’ heterochromic cyclitis patients. Invest Ophthalmol Vis Sci. 1989;30:443–448
   PubMed Web of Science ®Google Scholar
• Spriewald BM, Lefter C, Huber I, et al. A suggestive association of Fuchs heterochromic cyclitis with cytotoxic T cell antigen 4 gene polymorphism. Ophthalmic Res. 2007;39:116–120
   PubMed Web of Science ®Google Scholar
• Caspi RR. A look at autoimmunity and inflammation in the eye. J Clin Invest. 2010;120:3073–3083
   PubMed Web of Science ®Google Scholar
• Curnow SJ, Scheel-Toellner D, Jenkinson W, et al. Inhibition of T cell apoptosis in the aqueous humor of patients with uveitis by IL-6/soluble IL-6 receptor trans-signaling. J Immunol. 2004;173:5290–5297
   PubMed Web of Science ®Google Scholar
• Lin CC, Yang CY, Shih YL, et al. Rubella seroepidemiology and estimations of the catch-up immunisation rate and persistence of antibody titers in pregnant women in Taiwan. BJOG. 2011;118:706–712
   PubMed Web of Science ®Google Scholar
• Hyde TB, Kruszon-Moran D, McQuillan GM, et al. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached? Clin Infect Dis. 2006;43:S146–A150
   PubMed Web of Science ®Google Scholar
• O’Shea S, Parsons G, Best JM, et al. How well do low levels of rubella antibody protect? Lancet. 1981;2:1284
   PubMed Web of Science ®Google Scholar